Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

A robust approach to enhance tumor-selective accumulation of nanoparticles.

Qiao Y, Huang X, Nimmagadda S, Bai R, Staedtke V, Foss CA, Cheong I, Holdhoff M, Kato Y, Pomper MG, Riggins GJ, Kinzler KW, Diaz LA Jr, Vogelstein B, Zhou S.

Oncotarget. 2011 Jan-Feb;2(1-2):59-68.

PMID:
21378416
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.

MacEwan SR, Callahan DJ, Chilkoti A.

Nanomedicine (Lond). 2010 Jul;5(5):793-806. doi: 10.2217/nnm.10.50. Review.

PMID:
20662649
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.

Sultana S, Khan MR, Kumar M, Kumar S, Ali M.

J Drug Target. 2013 Feb;21(2):107-25. doi: 10.3109/1061186X.2012.712130. Epub 2012 Aug 9. Review.

PMID:
22873288
[PubMed - indexed for MEDLINE]
4.

Role of integrated cancer nanomedicine in overcoming drug resistance.

Iyer AK, Singh A, Ganta S, Amiji MM.

Adv Drug Deliv Rev. 2013 Nov;65(13-14):1784-802. doi: 10.1016/j.addr.2013.07.012. Epub 2013 Jul 21. Review.

PMID:
23880506
[PubMed - indexed for MEDLINE]
5.

The ligand nanoparticle conjugation approach for targeted cancer therapy.

Karra N, Benita S.

Curr Drug Metab. 2012 Jan;13(1):22-41. Review.

PMID:
21892918
[PubMed - indexed for MEDLINE]
6.

Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours.

Cegnar M, Kristl J, Kos J.

Expert Opin Biol Ther. 2005 Dec;5(12):1557-69. Review.

PMID:
16318420
[PubMed - indexed for MEDLINE]
7.

The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.

Maeda H, Nakamura H, Fang J.

Adv Drug Deliv Rev. 2013 Jan;65(1):71-9. doi: 10.1016/j.addr.2012.10.002. Epub 2012 Oct 23. Review.

PMID:
23088862
[PubMed - indexed for MEDLINE]
8.

Polymeric nanoparticles for cancer therapy.

Parveen S, Sahoo SK.

J Drug Target. 2008 Feb;16(2):108-23. doi: 10.1080/10611860701794353 . Review.

PMID:
18274932
[PubMed - indexed for MEDLINE]
9.

The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.

Huynh NT, Roger E, Lautram N, BenoƮt JP, Passirani C.

Nanomedicine (Lond). 2010 Nov;5(9):1415-33. doi: 10.2217/nnm.10.113. Review.

PMID:
21128723
[PubMed - indexed for MEDLINE]
10.

Peptide targeted lipid nanoparticles for anticancer drug delivery.

Pearce TR, Shroff K, Kokkoli E.

Adv Mater. 2012 Jul 24;24(28):3803-22, 3710. doi: 10.1002/adma.201200832. Epub 2012 Jun 5. Review.

PMID:
22674563
[PubMed - indexed for MEDLINE]
11.

Nuclear drug delivery for cancer chemotherapy.

Sui M, Liu W, Shen Y.

J Control Release. 2011 Oct 30;155(2):227-36. doi: 10.1016/j.jconrel.2011.07.041. Epub 2011 Aug 6. Review.

PMID:
21846484
[PubMed - indexed for MEDLINE]
12.

Extravasation of polymeric nanomedicines across tumor vasculature.

Danquah MK, Zhang XA, Mahato RI.

Adv Drug Deliv Rev. 2011 Jul 18;63(8):623-39. doi: 10.1016/j.addr.2010.11.005. Epub 2010 Dec 6. Review.

PMID:
21144874
[PubMed - indexed for MEDLINE]
13.

Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles.

Zhang C, Pei J, Kumar D, Sakabe I, Boudreau HE, Gokhale PC, Kasid UN.

Methods Mol Biol. 2007;361:163-85. Review.

PMID:
17172711
[PubMed - indexed for MEDLINE]
14.

Lipid nanomedicines for anticancer drug therapy.

Estella-Hermoso de Mendoza A, Campanero MA, Mollinedo F, Blanco-Prieto MJ.

J Biomed Nanotechnol. 2009 Aug;5(4):323-43. Review.

PMID:
20055079
[PubMed - indexed for MEDLINE]
15.

Polymer-protein and polymer-drug conjugates in cancer therapy.

Thanou M, Duncan R.

Curr Opin Investig Drugs. 2003 Jun;4(6):701-9. Review. Erratum in: Curr Opin Investig Drugs. 2003 Oct;4(10):1250.

PMID:
12901229
[PubMed - indexed for MEDLINE]
16.

Targeting of drugs and nanoparticles to tumors.

Ruoslahti E, Bhatia SN, Sailor MJ.

J Cell Biol. 2010 Mar 22;188(6):759-68. doi: 10.1083/jcb.200910104. Epub 2010 Mar 15. Review.

PMID:
20231381
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Active targeting strategies for anticancer drug nanocarriers.

Basile L, Pignatello R, Passirani C.

Curr Drug Deliv. 2012 May;9(3):255-68. Review.

PMID:
22452402
[PubMed - indexed for MEDLINE]
18.

Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.

Greish K.

J Drug Target. 2007 Aug-Sep;15(7-8):457-64. Review.

PMID:
17671892
[PubMed - indexed for MEDLINE]
19.

Nanoparticles for tumor targeted therapies and their pharmacokinetics.

Wang J, Sui M, Fan W.

Curr Drug Metab. 2010 Feb;11(2):129-41. Review.

PMID:
20359289
[PubMed - indexed for MEDLINE]
20.

Drug delivery and transport to solid tumors.

Jang SH, Wientjes MG, Lu D, Au JL.

Pharm Res. 2003 Sep;20(9):1337-50. Review.

PMID:
14567626
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk